Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The scalp stratum corneum is the outermost layer of the scalp epidermis, consisting of keratin-filled corneocytes held together by a lipid matrix and specialized junctions called corneodesmosomes [1]. This structure serves as a critical physical and chemical barrier, protecting the underlying tissue from environmental insults and preventing excessive water loss [2]. In healthy scalp skin, a balanced process of desquamation occurs where proteolytic enzymes, such as kallikrein-related peptidases (KLKs), break down corneodesmosomes to allow individual cells to shed invisibly [3]. However, in conditions like dandruff and seborrheic dermatitis, this cohesion is disrupted—often by the metabolic byproducts of Malassezia fungi—leading to the premature shedding of large, visible clumps of corneocytes [1][4]. Therapeutic interventions often target this cohesion using keratolytics like salicylic acid, which promote desquamation by dissolving the intercellular cement, or antifungal agents like zinc pyrithione that restore barrier integrity by addressing microbial triggers [4][5]. Understanding the interplay between keratin filaments and the lipid-protein brick and mortar model is essential for developing treatments for various scalp scaling disorders [2]. Disruption of this complex leads to increased transepidermal water loss and heightened sensitivity to external irritants [2][5].
Keratolytic agents promote desquamation by dissolving the intercellular cement or degrading corneodesmosomal proteins, while antifungal agents restore barrier integrity by reducing microbial-induced inflammation and lipid disruption [1][4].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum structural complex (SC).